{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:35:43Z","timestamp":1777674943920,"version":"3.51.4"},"reference-count":24,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Tick-borne encephalitis (TBE) is a severe viral infection of the central nervous system transmitted by tick bites. Vaccination represents the only effective preventive measure, yet data on TBE vaccine effectiveness in Italy are lacking. This study aimed to evaluate TBE vaccine effectiveness and vaccination coverage in the province of Udine, an endemic area in the Friuli Venezia Giulia region of Northern Italy. Methods: We conducted a case\u2013control study using linked anonymized health databases of the region, including vaccination, laboratory, and hospital admission records from 2017 to 2025. Cases were defined as residents hospitalized with a diagnosis of TBE (ICD-9-CM 063.x or 321.2) and a positive anti-TBE IgM result in serum or cerebrospinal fluid. Controls were residents tested for anti-TBE IgM during the same period but not hospitalized for TBE. Vaccination history was retrieved from the regional vaccination registry. Vaccine effectiveness was estimated through logistic regression models comparing vaccinated and unvaccinated individuals. Results: Between 2017 and 2025, 21 confirmed TBE hospitalizations were recorded (mean annual incidence: 0.45\/100,000 inhabitants). The mean hospital stay was 13.8. Among 6065 individuals tested for anti-TBE IgM, 95.2% of cases and 81.8% of controls were unvaccinated. The estimated odds ratio of TBE hospitalization for individuals with \u22653 vaccine doses versus unvaccinated was 0.11 (95% CI: 0.02\u20130.88). Vaccination coverage in 2025 reached about 10% of the provincial population, with markedly higher coverage (up to 34%) in mountain districts compared with lowland areas (&lt;5%). Conclusions: Although limited by small sample size, this study provides the first real-world evidence of TBE vaccine effectiveness in an Italian endemic area. Vaccination is an effective preventive measure. Given the regional epidemiology and expected increase in tick activity due to climate change, strengthening vaccination uptake and public awareness in endemic districts is strongly recommended.<\/jats:p>","DOI":"10.3390\/vaccines14020164","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T15:23:14Z","timestamp":1770736994000},"page":"164","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Case\u2013Control Study on the Effectiveness of Tick-Borne Encephalitis Vaccination Against Hospitalizations in an Endemic Area in Northeastern Italy"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4071-0897","authenticated-orcid":false,"given":"Francesca","family":"Valent","sequence":"first","affiliation":[{"name":"SOC Igiene e Sanit\u00e0 Pubblica, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Degani","sequence":"additional","affiliation":[{"name":"SOC Igiene e Sanit\u00e0 Pubblica, Azienda Sanitaria Universitaria Friuli Centrale, 33100 Udine, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-borne encephalitis","volume":"371","author":"Lindquist","year":"2008","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.12998\/wjcc.v3.i5.430","article-title":"Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management","volume":"3","author":"Bogovic","year":"2015","journal-title":"World J. Clin. Cases"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"WHO Publication (2011). Vaccines against tick-borne encephalitis: WHO position paper\u2014recommendations. Vaccine, 29, 8769\u20138770.","DOI":"10.1016\/j.vaccine.2011.07.024"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"108052","DOI":"10.1016\/j.ijid.2025.108052","article-title":"Incidence of tick-borne encephalitis in unvaccinated populations across Europe (2020\u20132023)","volume":"160","author":"Halsby","year":"2025","journal-title":"Int. J. Infect. Dis."},{"key":"ref_5","unstructured":"Giunta Regionale del Friuli Venezia Giulia (2026, February 04). Delibera n. 1311 del 25 July 2012. Estensione Dell\u2019offerta Vaccinale Nella Regione FVG, Available online: https:\/\/mtom.regione.fvg.it\/storage\/\/2012_1311\/Testo%20della%20Delibera%20n%201311-2012.pdf."},{"key":"ref_6","unstructured":"Giunta Regionale del Friuli Venezia Giulia (2025, October 31). Delibera n. 1549 del 6 October 2023. Aggiornamento Dell\u2019offerta Vaccinale Per Adulti, Anziani e Soggetti a Rischio Nella Regione Friuli Venezia Giulia, Available online: https:\/\/mtom.regione.fvg.it\/storage\/\/2023_1549\/Testo%20integrale%20della%20Delibera%20n%201549-2023.pdf."},{"key":"ref_7","unstructured":"Giunta Regionale del Friuli Venezia Giulia (2025, October 31). Delibera n.345 del 25 March 2025. Aggiornamento Dell\u2019offerta Vaccinale e di Immunizzazione per Infanzia e Adolescenza Nella Regione Friuli Venezia Giulia, Available online: https:\/\/mtom.regione.fvg.it\/storage\/\/2025_345\/Testo%20integrale%20della%20Delibera%20n%20345-2025.pdf."},{"key":"ref_8","unstructured":"Agenzia Italiana del Farmaco (2025, November 03). TICOVAC, Available online: https:\/\/medicinali.aifa.gov.it\/it\/#\/it\/risultati?query=TICOVAC%20(MEDICINALE)&exact=true."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Panatto, D., Domnich, A., Amicizia, D., Reggio, P., and Iantomasi, R. (2022). Vaccination against Tick-Borne Encephalitis (TBE) in Italy: Still a Long Way to Go. Microorganisms, 10.","DOI":"10.3390\/microorganisms10020464"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1016\/j.vaccine.2023.10.014","article-title":"A systematic literature review of the effectiveness of tick-borne encephalitis vaccines in Europe","volume":"41","author":"Angulo","year":"2023","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1038\/s41598-025-86968-y","article-title":"Tick-borne encephalitis vaccine uptake, effectiveness, and impact in Sweden from 2018 to 2022","volume":"15","author":"Palmborg","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2300558","DOI":"10.2807\/1560-7917.ES.2024.29.18.2300558","article-title":"A combined cross-sectional analysis and case-control study evaluating tick-borne encephalitis vaccination coverage, disease and vaccine effectiveness in children and adolescents, Switzerland, 2005 to 2022","volume":"29","author":"Zens","year":"2024","journal-title":"Eurosurveillance"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"127854","DOI":"10.1016\/j.vaccine.2025.127854","article-title":"Tick-borne encephalitis: Burden of disease and impact of vaccination, Austria (2000\u20132024)","volume":"66","author":"Raffl","year":"2025","journal-title":"Vaccine"},{"key":"ref_14","unstructured":"Ministry of Health (2025, November 04). Decreto 7 Marzo 2022. Revisione del Sistema di Segnalazione Delle Malattie Infettive (PREMAL), Available online: https:\/\/www.gazzettaufficiale.it\/eli\/id\/2022\/04\/07\/22A02179\/SG."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jcv.2019.09.009","article-title":"An evaluation of serological methods to diagnose tick-borne encephalitis from serum and cerebrospinal fluid","volume":"120","author":"Reusken","year":"2019","journal-title":"J. Clin. Virol."},{"key":"ref_16","unstructured":"Agenzia Italiana del Farmaco. Comunicato (2026, February 04). Autorizzazione All\u2019immissione in Commercio Della Specialit\u00e0 Medicinale per Uso Umano \u00abTicovac\u00bb (GU Serie Generale n.70 del 25 March 2005), Available online: https:\/\/www.gazzettaufficiale.it\/eli\/id\/2005\/03\/25\/05A02728\/sg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"102372","DOI":"10.1016\/j.ttbdis.2024.102372","article-title":"Incidence, healthcare resource utilization and costs of hospitalized patients with tick-borne encephalitis (TBE) in Italy","volume":"15","author":"Scaggiante","year":"2024","journal-title":"Ticks Tick-Borne Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Vilibic-Cavlek, T., Ferenc, T., Vujica Ferenc, M., Bogdanic, M., Potocnik-Hunjadi, T., Sabadi, D., Savic, V., Barbic, L., Stevanovic, V., and Monaco, F. (2022). Cross-Reactive Antibodies in Tick-Borne Encephalitis: Case Report and Literature Review. Antibodies, 11.","DOI":"10.3390\/antib11040072"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/aje\/kwac203","article-title":"Current Challenges With the Use of Test-Negative Designs for Modeling COVID-19 Vaccination and Outcomes","volume":"192","author":"Shi","year":"2023","journal-title":"Am. J. Epidemiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/aje\/kww064","article-title":"Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness","volume":"184","author":"Sullivan","year":"2016","journal-title":"Am. J. Epidemiol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"M\u00fcller, M., Lintener, H., Henkel, V., Pilz, A., Halsby, K., Malerczyk, C., Madhava, H., Mo\u00efsi, J.C., Yu, H., and Schley, K. (2024). Does the Vaccination against Tick-Borne Encephalitis Offer Good Value for Money for Incidence Rates below the WHO Threshold for Endemicity? A Case Study for Germany. Vaccines, 12.","DOI":"10.3390\/vaccines12101165"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Trevisan, G., Ruscio, M., Cinco, M., Nan, K., Forgione, P., Di Meo, N., Tranchini, P., Nacca, M., Trincone, S., and Rimoldi, S.G. (2023). The history of Lyme disease in Italy and its spread in the Italian territory. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1128142"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/jme\/tjaa220","article-title":"Possible Effects of Climate Change on Ixodid Ticks and the Pathogens They Transmit: Predictions and Observations","volume":"58","author":"Ogden","year":"2021","journal-title":"J. Med. Entomol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"taaf115","DOI":"10.1093\/jtm\/taaf115","article-title":"Tick-borne encephalitis in international travellers: A systematic review and vaccine recommendations","volume":"32","author":"Srinivasan","year":"2025","journal-title":"J. Travel. Med."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/2\/164\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:21:09Z","timestamp":1770891669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/2\/164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["vaccines14020164"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14020164","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}